Pages that link to "Q35918881"
Jump to navigation
Jump to search
The following pages link to The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study (Q35918881):
Displaying 7 items.
- Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients (Q28080163) (← links)
- Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study (Q49635743) (← links)
- Hypertension in malignancy-an underappreciated problem. (Q55071881) (← links)
- Prognostic impact of tumor-infiltrating CD276/Foxp3-positive lymphocytes and associated circulating cytokines in patients undergoing radical nephrectomy for localized renal cell carcinoma (Q64271721) (← links)
- Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis. (Q64917096) (← links)
- Clinical Significance of Tumor Size, Pathological Invasion Sites Including Urinary Collecting System and Clinically Detected Renal Vein Thrombus as Predictors for Recurrence in pT3a Localized Renal Cell Carcinoma (Q90363559) (← links)
- Exploration of IMDC model in patients with metastatic renal cell carcinoma using targeted agents: a meta-analysis (Q92800351) (← links)